from: 11:15 to: 12:00

Cellular anti-TB immunity in human populations (Presentation)

Lecturer: Matthieu Perreau, CHUV, Lausanne
Location: Swiss TPH, Alpamayo (Seminar Room 1)
Event category: Seminar (46489-01)


from: 17:15

“Population Pharmacokinetic Modelling and Simulation of Anti-Malaria drugs to optimize dosing in neglected populations”

Lecturer: Ali Ali (Supervision: Tom Smith and Melissa Penny)
Location: Hörsaal 1, Socinstrasse 57, Basel
Event category: Seminar (46491-01)

New Swiss TPH Building Allschwil: Architectural Tender has been decided

The Kunz und Mösch GmbH architect office in Basel has been awarded the contract for the new Swiss Tropical and Public Health Institute (Swiss TPH) building at its new location at the BaseLink site in Allschwil. The design for the new building expertly combines laboratory, training and working areas for research, teaching and service activities.


World TB Day

On 24 March, we commemorate World TB Day. Tuberculosis remains one of the top 10 causes of death worldwide with annually 1.8 million deaths. 250,000 of them are due to resistance to regular treatment. Swiss TPH aims at contributing to the fight against TB, through our activities in basic research, clinical trials and health interventions.


Prof. Günther Fink elected as Eckenstein-Geigy Professor

The Universitätsrat of the University of Basel has elected Prof. Günther Fink as the new Eckenstein-Geigy professor in Household Economy at Swiss TPH and the University of Basel.

Günther Fink, an expert in International Health Economics, is currently a faculty member of the Harvard T.H. Chan School of Public Health in Boston.

He will join Swiss TPH in the second half of 2017. This newly established professorship has been made possible by a generous endowment of the Eckenstein-Geigy foundation.


Why Swiss TPH?


Students, scientists and employers explain what Swiss TPH is really all about!




Working at Swiss TPH

Chronic Disease Clinic Ifakara: New Documentary film

For the last 10 years - thanks to early diagnosis and the deployment of antiretroviral therapy - African children infected with HIV have been able to deal with the illness not as a death sentence, but as a chronic disease and thus live a life with the same opportunities as any other child. Although behind these hopeful stories hide other dramas...

In this documentary film shot at the Chronic Disease Clinic in Ifakara (CDCI) some of them explain how their lifes are... They are the Positive Kids.

More on CDCI

Human odour-baited traps reduce malaria transmission

The use of a newly-developed mosquito trap incorporating human odour has resulted in a 70% decline in the population of the most significant malaria mosquito on the Kenyan island of Rusinga. As a result the number of malaria infections declined by 30% according to a «Lancet»-study published today.

Thomas Smith explains the new solar-driven door-baited trap on Tele Basel.

More on the new Odour-baited trap

WHO: Key facts about Malaria

Half of the world's population is at risk of Malaria. This video is an introduction to this disease with a few key facts about its global epidemiology, symptoms, mode of transmission through infected mosquitoes, its diagnosis and treatment and, moreover, the main means to prevent its transmission and limit its spreading.

More on Malaria

WHO: Global malaria progress and challenges in 2016

Over the past 15 years, there has been a dramatic decline in the global burden of malaria. Since 2000, nearly 60 countries have reduced their malaria cases by 75% or more, and the rate of new cases has decreased by 37% globally. But our journey is far from over. In 2015 alone, more than 400 000 people died of malaria, and there were 214 million new cases of the disease.

For more

22.03.2017 - 11:34:23

World TB Day

On 24 March, we commemorate World TB Day. Tuberculosis remains one of the top 10 causes of death worldwide with annually 1.8 million deaths. 250,000 of them are due to resistance... More...

08.03.2017 - 20:00:00

High Prevalence and Incidence of Hypertension among Africans Living with HIV

About 12% of people living with HIV in rural Tanzania have hypertension at the moment of HIV diagnosis. An additional 10% will develop hypertension during the first months of... More...

03.03.2017 - 08:05:59

The Achilles Heel of Plasmodia - Advances in Vaccine Development against Malaria

The protein CyRPA could be an important component for an efficient vaccine against Plasmodium falciparum, the most deadly of all malarial pathogens. Scientists from the Swiss... More...